UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines?

Journal of neurosurgery. Pediatrics, 2022-12, Vol.30 (6), p.555

2022

Link zum Volltext

Verfügbarkeit prüfen

Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide

Oncogene, 2019-10, Vol.38 (42), p.6867-6879

2019

Link zum Volltext

Verfügbarkeit prüfen

Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma

Nature communications, 2018-10, Vol.9 (1), p.4121-9, Article 4121

2018

Link zum Volltext

Verfügbarkeit prüfen

Development of an EGFRvIII specific recombinant antibody

BMC biotechnology, 2010-10, Vol.10 (1), p.72-72, Article 72

2010

Link zum Volltext

Verfügbarkeit prüfen

Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion

Scientific reports, 2019-09, Vol.9 (1), p.14020-12, Article 14020

2019

Link zum Volltext

Verfügbarkeit prüfen

A-Type Lamins Regulate Retinoblastoma Protein Function by Promoting Subnuclear Localization and Preventing Proteasomal Degradation

Proceedings of the National Academy of Sciences - PNAS, 2004-06, Vol.101 (26), p.9677-9682

2004

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor Variant III Contributes to Cancer Stem Cell Phenotypes in Invasive Breast Carcinoma

Cancer research (Chicago, Ill.), 2012-05, Vol.72 (10), p.2657-2671

2012

Link zum Volltext

Verfügbarkeit prüfen

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas

Journal of neuro-oncology, 2012-07, Vol.108 (3), p.395-402

2012

Link zum Volltext

Verfügbarkeit prüfen

Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide

Oncogene, 2020-02, Vol.39 (9), p.2029-2029

2020

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma

Nature communications, 2018-11, Vol.9 (1), p.4651-1, Article 4651

2018

Link zum Volltext

Verfügbarkeit prüfen

The Invasive Nature of Glioblastoma

World neurosurgery, 2013-09, Vol.80 (3), p.279-280

2013

Link zum Volltext

Verfügbarkeit prüfen

The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ‐dependent inhibition of the AKT pathway

EMBO molecular medicine, 2016-05, Vol.8 (5), p.511-526

2016

Link zum Volltext

Verfügbarkeit prüfen

Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2

PloS one, 2007-09, Vol.2 (9), p.e963-e963

2007

Link zum Volltext

Verfügbarkeit prüfen

γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth

BMC cancer, 2015-04, Vol.15 (1), p.225-225, Article 225

2015

Link zum Volltext

Verfügbarkeit prüfen

Stabilization of the Retinoblastoma Protein by A-Type Nuclear Lamins Is Required for INK4A-Mediated Cell Cycle Arrest

Molecular and Cellular Biology, 2006-07, Vol.26 (14), p.5360-5372

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3049: Tumor treating fields induce DNA damage and apoptosis in medulloblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.3049-3049

2021

Link zum Volltext

Verfügbarkeit prüfen

Constitutive Activity of JNK2α2 Is Dependent on a Unique Mechanism of MAPK Activation

The Journal of biological chemistry, 2008-12, Vol.283 (50), p.34935-34945

2008

Link zum Volltext

Verfügbarkeit prüfen

Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT

Neurosurgery clinics of North America, 2012-04, Vol.23 (2), p.237-246

2012

Link zum Volltext

Verfügbarkeit prüfen

CSIG-44. TREATMENT WITH THE CASEIN KINASE 2 INHIBITOR, CX-4945, SENSITIZES MEDULLOBLASTOMA TO TEMOZOLOMIDE

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi52-vi53

2018

Link zum Volltext

Verfügbarkeit prüfen

Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells

Journal of molecular and genetic medicine, 2013-12, Vol.8 (1)

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1833: Tumor treating fields induce DNA damage and apoptosis in medulloblastoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.1833-1833

2022

Link zum Volltext

Verfügbarkeit prüfen

Measuring the Constitutive Activation of c-Jun N-terminal Kinase Isoforms

Constitutive Activity in Receptors and Other Proteins, Part A, 2010, Vol.484, p.531-548

2010

Link zum Volltext

Verfügbarkeit prüfen

Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway

Oncogene, 2015-07, Vol.34 (28), p.3688-3699

2015

Link zum Volltext

Verfügbarkeit prüfen

PDTB-04. CASEIN KINASE 2 REGULATES EXPRESSION AND ACTIVITY OF MYC IN GROUP 3 MEDULLOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (suppl_6), p.vi150-vi150

2016

Link zum Volltext

Verfügbarkeit prüfen

DDIS-23. A COMBINATORIAL TREATMENT USING A CK2 INHIBITOR, CX-4945, AND TMZ DECREASED MEDULLOBLASTOMA TUMORIGENESIS

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi63-vi63

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(55)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(65)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines?

Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide

Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma

Development of an EGFRvIII specific recombinant antibody

Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion

A-Type Lamins Regulate Retinoblastoma Protein Function by Promoting Subnuclear Localization and Preventing Proteasomal Degradation

Epidermal Growth Factor Receptor Variant III Contributes to Cancer Stem Cell Phenotypes in Invasive Breast Carcinoma

Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas

Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide

Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma

The Invasive Nature of Glioblastoma

The anti‐hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ‐dependent inhibition of the AKT pathway

Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2

γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth

Stabilization of the Retinoblastoma Protein by A-Type Nuclear Lamins Is Required for INK4A-Mediated Cell Cycle Arrest

Abstract 3049: Tumor treating fields induce DNA damage and apoptosis in medulloblastoma

Constitutive Activity of JNK2α2 Is Dependent on a Unique Mechanism of MAPK Activation

Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT

CSIG-44. TREATMENT WITH THE CASEIN KINASE 2 INHIBITOR, CX-4945, SENSITIZES MEDULLOBLASTOMA TO TEMOZOLOMIDE

Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells

Abstract 1833: Tumor treating fields induce DNA damage and apoptosis in medulloblastoma

Measuring the Constitutive Activation of c-Jun N-terminal Kinase Isoforms

Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway

PDTB-04. CASEIN KINASE 2 REGULATES EXPRESSION AND ACTIVITY OF MYC IN GROUP 3 MEDULLOBLASTOMA

DDIS-23. A COMBINATORIAL TREATMENT USING A CK2 INHIBITOR, CX-4945, AND TMZ DECREASED MEDULLOBLASTOMA TUMORIGENESIS

Suchergebnisse filtern